Altarum Institute is a nonprofit health systems research and consulting organization serving government, nonprofit and private-sector clients. With the rigor of the finest research institution, consulting skills honed for nearly seven decades, and an abiding commitment to the public interest, Altarum Institute enables better care and better health for all people. Altarum’s mission is to serve the public good by solving complex systems problems to improve human health, integrating research, technology, analysis, and consulting skills.Altarum Institute traces its history back to 1946 with the founding of the Willow Run Laboratory in Ypsilanti, Michigan. In 1972, the Willow Run Laboratory was renamed the Environmental Research Institute of Michigan . In 2001, after much of ERIM's organization and contracts were collected into a for-profit entity and sold to Veridian Corp., ERIM acquired Vector Research, Inc. , a leading provider of health care forecasting models and decision support tools for federal and state government clients. Later that year, ERIM became Altarum Institute. In 2006, to further advance and focus its expertise in health care, Altarum acquired Health Systems Research, Inc. and divested itself of its Environmental and Emerging Technologies Division to Michigan Technological University, forming the Michigan Tech Research Institute.In 2009, Altarum acquired KAI Research, Inc., adding clinical research and research-based knowledge to its portfolio. In 2011, Altarum acquired Palladian Partners, a leader in the health communications field. Wikipedia.
Schuster J.L.,Altarum Institute
Health Affairs | Year: 2014
A woman living with chronic pain tries to manage her condition while maneuvering through the maze of opioid medications. © 2014 by Project HOPE - The People-to-People Health Foundation.
Korda H.,Altarum Institute
Journal of Public Health Management and Practice | Year: 2013
Fidelity of implementation in replicating evidence-based health promotion interventions, to ensure implementation as designed and proven through research, is crucial if evidence-based community and population health interventions are to achieve promised results but can be difficult to attain in practice. This article highlights major challenges, considerations, and strategies associated with fidelity as public health care practitioners implement evidence-based interventions and bring them to scale in the field. There is need for sharing information about "what works" in implementing these interventions with fidelity, as well sharing information about implementation challenges and improvements to intervention design. Fidelity is important if practitioners are to obtain results and outcomes planned by intervention developers and is an essential value proposition for evidence-based public health practice and population health improvement. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Roehrig C.S.,Altarum Institute |
Rousseau D.M.,Kaiser Family Foundation
Health Affairs | Year: 2011
Some prior research has suggested that health spending for many diseases has been driven more by increases in so-called treated prevalence-the number of people receiving treatment for a given condition-than by increases in cost per case. Our study reached a different conclusion. We examined treated prevalence, clinical prevalence-the number of people with a given disease, treated or not- and cost per case across all medical conditions between 1996 and 2006. Over this period, three-fourths of the increase in real per capita health spending was attributable to growth in cost per case, while treated prevalence accounted for about one-fourth of spending growth. Our evidence suggests that most of the treated-prevalence effect is due to an increase in the share of eligible people being treated rather than an increase in clinical prevalence of diseases. We conclude that efforts to curb health spending should focus more on reining in cost per case. © 2011 Project HOPE- The People-to-People Health Foundation, Inc.
Ricketts S.,Epidemiology |
Schwalberg R.,Altarum Institute
Perspectives on Sexual and Reproductive Health | Year: 2014
Context: Long-acting reversible contraceptive (LARC) methods are recommended for young women, but access is limited by cost and lack of knowledge among providers and consumers. The Colorado Family Planning Initiative (CFPI) sought to address these barriers by training providers, financing LARC method provision at Title X-funded clinics and increasing patient caseload. Methods: Beginning in 2009, 28 Title X-funded agencies in Colorado received private funding to support CFPI. Caseloads and clients' LARC use were assessed over the following two years. Fertility rates among low-income women aged 15-24 were compared with expected trends. Abortion rates and births among high-risk women were tracked, and the numbers of infants receiving services through the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) were examined. Results: By 2011, caseloads had increased by 23%, and LARC use among 15-24-year-olds had grown from 5% to 19%. Cumulatively, one in 15 young, low-income women had received a LARC method, up from one in 170 in 2008. Compared with expected fertility rates in 2011, observed rates were 29% lower among low-income 15-19-year-olds and 14% lower among similar 20-24-year-olds. In CFPI counties, the proportion of births that were high-risk declined by 24% between 2009 and 2011; abortion rates fell 34% and 18%, respectively, among women aged 15-19 and 20-24. Statewide, infant enrollment in WIC declined 23% between 2010 and 2013. Conclusions: Programs that increase LARC use among young, low-income women may contribute to declines in fertility rates, abortion rates and births among high-risk women. © 2014 by the Guttmacher Institute.
Singer A.E.,RAND Corporation |
Meeker D.,University of Southern California |
Teno J.M.,Brown University |
Lynn J.,Altarum Institute |
And 2 more authors.
Annals of Internal Medicine | Year: 2015
Background: Calls for improvement in end-of-life care have focused attention on the management of pain and other troubling symptoms at the end of life. Objective: To describe changes in pain intensity and symptom prevalence during the last year of life from 1998 to 2010. Design: Observational study. Setting: The HRS (Health and Retirement Study), a nationally representative longitudinal survey of community-dwelling U.S. residents aged 51 years or older. Participants: 7204 HRS participants who died while enrolled in the study and their family respondents. Measurements: Proxy-reported pain during the last year of life and other symptoms for at least 1 month during the last year of life. Trends in pain intensity and symptom prevalence were analyzed for all decedents and within the categories of sudden death, cancer, congestive heart failure or chronic lung disease, and frailty. Results: Between 1998 and 2010, proxy reports of the prevalence of any pain increased for all decedents from 54.3% (95% CI, 51.6% to 57.1%) to 60.8% (CI, 58.2% to 63.4%), an increase of 11.9% (CI, 3.1% to 21.4%). Reported prevalences of depression and periodic confusion also increased for all decedents by 26.6% (CI, 14.5% to 40.1%) and 31.3% (CI, 18.6% to 45.1%), respectively. Individual symptoms increased in prevalence among specific decedent categories, except in cancer, which showed no significant changes. The prevalence of moderate or severe pain did not change among all decedents or in any specific decedent category. Limitation: Use of proxy reports and limited information about some patient and surrogate variables. Conclusion: Despite national efforts to improve end-of-life care, proxy reports of pain and other alarming symptoms in the last year of life increased from 1998 to 2010. © 2015 American College of Physicians.